WASHINGTON: The U.S. House Oversight and Reform Committee has questioned four companies over their plans to use a tax provision passed in a COVID-19-related law to address their litigation costs tied to their role in the nation’s opioid crisis, it said in a statement on Friday.
The panel sent …
